HIGHLIGHTS
- who: Dean A. Fennell from the University of Leicester and University Hospitals of Leicester NHS Trust, Leicester, UK have published the Article: Olaparib maintenance versus placebo monotherapy in patients with advanced non-small cell lung cancer (PIN): A multicentre, randomised, controlled, phase 2 trial, in the Journal: (JOURNAL)
- what: The aim of the PIN trial was to establish whether maintenance olaparib in patients with DNA damage sensitive NSCLC, as measured by PFS, has sufficient anti-tumour activity to warrant further Role of the funding source This study has completed accrual and presents a logical progression . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.